公开(公告)号：US08367731B2

公开(公告)日：2013-02-05

申请号：US11921224

申请日：2006-05-03

申请人： Anders Wieslander ,  Ola Carlsson ,  Magnus Braide ,  Per Kjellstrand

发明人： Anders Wieslander ,  Ola Carlsson ,  Magnus Braide ,  Per Kjellstrand

IPC分类号： A01N43/00 ,  A01N37/00

CPC分类号： A61M1/287 ,  A61K9/0019 ,  A61K31/194

摘要： The present invention concerns a peritoneal dialysis fluid with enhanced ultrafiltration during the dialysis dwell period. According to the present invention this is achieved by a peritoneal dialysis fluid comprising sodium ions, osmotic agent and a buffer, characterised in that it comprises citrate at a level of 4 to 10 mM in a final solution ready for use.

公开(公告)号：US20090306211A1

公开(公告)日：2009-12-10

申请号：US11921224

申请日：2006-05-03

申请人： Anders Wieslander ,  Ola Carlsson ,  Magnus Braide ,  Per Kjellstrand

发明人： Anders Wieslander ,  Ola Carlsson ,  Magnus Braide ,  Per Kjellstrand

IPC分类号： A61K31/194 ,  A61P7/08

CPC分类号： A61M1/287 ,  A61K9/0019 ,  A61K31/194

摘要： The present invention concerns a peritoneal dialysis fluid with enhanced ultrafiltration during the dialysis dwell period. According to the present invention this is achieved by a peritoneal dialysis fluid comprising sodium ions, osmotic agent and a buffer, characterised in that it comprises citrate at a level of 4 to 10 mM in a final solution ready for use.

摘要翻译： 本发明涉及在透析停留期间具有增强的超滤的腹膜透析液。 根据本发明，这是通过包含钠离子，渗透剂和缓冲剂的腹膜透析液来实现的，其特征在于，在最终的溶液中，其含有4至10mM的柠檬酸盐。